Latest News and Press Releases
Want to stay updated on the latest news?
-
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SVRA
-
On May 27, 2025, Savara revealed the FDA refused to file its MOLBREEVI BLA due to insufficient CMC data, causing shares to fall $0.90, or 31.69%, to $1.94.
-
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23,...
-
LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Savara, Inc., (“Savara” or the "Company") (NASDAQ: SVRA) investors off a class action on behalf of investors that bought...
-
The complaint alleges Savara misled investors about its MOLBREEVI BLA readiness; the FDA’s refusal to file caused shares to drop 31.7% to $1.94.
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Savara To Contact Him Directly To Discuss Their Options If you...
-
LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Savara, Inc., (“Savara” or the "Company") (NASDAQ: SVRA) investors off a class action on behalf of investors that bought...
-
Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SVRA